Pioglitazone-d4 (major)

• CAT Number: R005713
• CAS Number: 1134163-31-7
• Molecular Formula: C19H20N2O3S
• Molecular Weight: 360.464
• Purity: ≥95%
• Synonyms: 5-[[4-[2-(5-Ethyl-2-pyridinyl]ethoxy-d4]phenyl]methyl]-2,4-thiazolidinedione; AD-4833-d4; Actos-d4; U-72107A-d4
• Storage: -20°C
• IUPAC Name: 5-[[4-[1,1,2,2-tetradeuterio-2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
• InChI: InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)/i9D2,10D2
• InChIKey: HYAFETHFCAUJAY-YQUBHJMPSA-N
• SMILES: CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3

Pioglitazone-d4 (major) is a deuterated form of the antidiabetic drug Pioglitazone, essential for advanced pharmaceutical and biochemical research. Featuring four deuterium atoms, it offers enhanced stability and precision in isotopic labeling. This compound is ideal for mass spectrometry and nuclear magnetic resonance (NMR) studies, facilitating the investigation of metabolic pathways and drug interactions. Widely used in diabetes research, pharmacokinetic studies, and drug development, Pioglitazone-d4 (major) ensures reliable and accurate analytical results, making it a crucial tool for scientists and researchers.